eMediNexus    08 February 2018

In patients with stable cardiovascular disease at very high risk for CVD events (expected 10-year event rate of greater than 25 percent), such as those in the proposed NCEP guidelines, start high-intensity statin therapy plus a ………………rather than targeting a goal LDL-C.

  1. PCSK9-ab
  2. Ezetimibe
  3. Fenofibrate
  4. Plasmapheresis

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.